AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health
AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health AstraZeneca has announced a $400 million investment in its global AZ Forest programme,…
Positive Phase III results for Roche’s OCREVUS (ocrelizumab) twice a year, 10-minute subcutaneous injection in patients with multiple sclerosis
Positive Phase III results for Roche’s OCREVUS (ocrelizumab) twice a year, 10-minute subcutaneous injection in patients with multiple sclerosis Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase…
Gilead Partners with CHAI and Penta to Improve Treatment and Adherence Rates Among Children with HIV in Low and Middle Income Countries
Gilead Partners with CHAI and Penta to Improve Treatment and Adherence Rates Among Children with HIV in Low and Middle Income Countries Gilead Sciences, Inc. (Nasdaq: GILD) is pleased to…
FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis
FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug…
AbbVie secures positive CHMP opinion for atogepant for the preventive treatment of adults with migraine
AbbVie secures positive CHMP opinion for atogepant for the preventive treatment of adults with migraine AbbVie (NYSE: ABBV) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for…
Bayer extends partnership with Peking University to foster pharmaceutical innovation in China
Bayer extends partnership with Peking University to foster pharmaceutical innovation in China Bayer and Peking University (PKU) will collaborate to foster the translation of basic pharmaceutical research into drug discovery…
Leadership in Emergencies learning journey completed by new AFRO cohort
Leadership in Emergencies learning journey completed by new AFRO cohort The WHO African Region and the WHO Emergency Hub in Nairobi hosted a Leadership in Emergencies workshop in Kenya mid-May…
European Commission approves Roche’s fixed-duration Columvi (glofitamab) for people with relapsed or refractory diffuse large B-cell lymphoma
European Commission approves Roche’s fixed-duration Columvi (glofitamab) for people with relapsed or refractory diffuse large B-cell lymphoma Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC)…
Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer
Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Hillary Bochniak as Chief Human Resources…
Medicines and Healthcare Products Regulatory Agency authorizes G SK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults
Medicines and Healthcare Products Regulatory Agency authorizes G SK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults GSK plc (LSE/NYSE: GSK) today announced that the Medicines and…
Unlocking the mystery of long-lasting cancer treatment
Unlocking the mystery of long-lasting cancer treatmentUnlocking the mystery of long-lasting cancer treatment New insights explaining why some children have a longer remission than others after having cutting-edge CAR T-cell…
Artificial cells demonstrate that “life finds a way”
Artificial cells demonstrate that “life finds a way” Listen, if there’s one thing the history of evolution has taught us is that life will not be contained. Life breaks free.…